The study of risk factor for congenital dacryocystitis
Background: Congenital nasolacrimal duct obstruction is inflammation of lacrimal sac due to nasolacrimal duct obstruction in children. Congenital nasolacrimal duct obstruction is a common disorder in infants, with up to 20% of all newborns suffering from epiphora during the first year of life. The purpose of this study is examining the various risk factors in patients of congenital nasolacrimal duct obstruction.
Method: In this study, 121 patients were examined in L.N. Medical College and J.K Hospital, Kolar Road, Bhopal between June to July to August 2015.A clinical examination was being conducted in the children below age of 3 years after the history taking started by torch light examination, slit lamp examination, and the regurgitation test was being done. All the other conditions which presented like complaints of congenital Dacryocystitis like–Opthalmia Neonatorum, Congenital Glaucoma, allergic conjunctivitis, trauma to eye were being ruled out. Mothers of the children were asked to fill the Questionnaire about risk factor of Congenital nasolacrimal duct obstruction. The awareness about the disease in the mothers via the above questionnaire whether the mothers were familiar with the disease or not was asked.
Results: 121 patients were seen over the period under review out of which 60% were males. Most common age at the presentation was between 0 to 2 months. 2 significant risk factors were observed, Prematurity and Poor hygienic status in this study.
Conclusion: Current study done to find association of various risk factors. A further study is needed in this field to find any other risk factors responsible for the high incidence of congenital Dacryocystitis and all the mothers need to be educated regarding these risk factors, and awareness should be created in the mothers.
2. Paul TO, Shepherd R. Congenital nasolacrimal duct obstruction: natural history and the timing of optimal intervention. J Pediatr Ophthalmol Strabismus. 1994;31 (6): 362-367.
3. Young JD, Mac Ewen CJ. Managing congenital lacrimal obstruction in general practice. BMJ. 1997; 315 (7103):293-296. doi:10.1136/bmj.315.7103.293
4. Kapadia MK, Freitag SK, Woog JJ. Evaluation and management of congenital nasolacrimal duct obstruction. Otolaryngol Clin North Am. 2006;39(5): 959-977, vii. doi:10.1016/j.otc.2006.08.004
5. Paul TO. Medical management of congenital nasolacrimal duct obstruction. Pediatr Ophthalmol Strabismus. 1985;22(2):68-70.
6. Repka MX, Melia BM, Beck RW, Chandler DL, Fishman DR, Goldblum TA et al Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age. J AAPOS. 2008; 12(5): 451-455.doi: 10.1016/j.jaapos. 2008. 07.001
7. Lorena SH, Silva JA, Scarpi MJ. Congenital nasolacrimal duct obstruction in premature children. J Pediat Ophthalmol Strabis. 2013;50(4):239-244.doi: 10.3390/diseases6040096.
8. Nordlow W, Vennerholm I. Congenital atresiae of the lacrimal passages: their occurrence and treatment. Acta Ophthalmol. 1953;31(4):367-371.
9. MacEwen CJ, Young JD. Epiphora during the first year of life. Eye (Lond). 1991;5(Pt 5):596-600. doi:10. 1038/eye.1991.103
10. Ffooks OO. Dacryocystitis in infancy. Br J Ophthalmol. 1962;46(7):422-434.doi:10.1136/bjo.46.7.422
11. Aldahash FD, Al-Mubarak MF, Alenezi SH, Al-Faky YH. Risk factors for developing congenital nasolacrimal duct obstruction. Saudi journal of ophthalmology. 2014; 28(1):58-60. doi: 10.1016/j.sjopt. 2013. 09.007
Copyright (c) 2019 Author (s). Published by Siddharth Health Research and Social Welfare Society
This work is licensed under a Creative Commons Attribution 4.0 International License.